| 0.9 |
0.9 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.8 |
1.6 |
GO:1903707 |
negative regulation of homeostatic process(GO:0032845) negative regulation of erythrocyte differentiation(GO:0045647) negative regulation of hemopoiesis(GO:1903707) |
| 0.7 |
0.7 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.7 |
0.7 |
GO:0032411 |
regulation of transporter activity(GO:0032409) positive regulation of transporter activity(GO:0032411) |
| 0.6 |
1.8 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.6 |
1.8 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.6 |
1.8 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.6 |
2.3 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.6 |
3.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.5 |
1.6 |
GO:0007109 |
obsolete cytokinesis, completion of separation(GO:0007109) protein hexamerization(GO:0034214) |
| 0.4 |
0.9 |
GO:0034723 |
DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 |
1.7 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.4 |
1.6 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.4 |
1.9 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.4 |
0.4 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.4 |
1.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.4 |
1.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.4 |
2.5 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.3 |
2.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.3 |
3.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 |
1.0 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
0.3 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.3 |
1.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.3 |
0.3 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.3 |
0.3 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.3 |
0.9 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.3 |
1.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.3 |
0.8 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.3 |
2.1 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.3 |
0.3 |
GO:0043523 |
regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
| 0.2 |
2.5 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.2 |
1.0 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.2 |
0.7 |
GO:2000644 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
| 0.2 |
2.4 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.2 |
1.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 |
0.5 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.2 |
0.7 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 |
1.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
2.7 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.2 |
0.7 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.2 |
0.7 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.2 |
0.9 |
GO:0051567 |
histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
| 0.2 |
1.1 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.2 |
0.7 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
| 0.2 |
0.6 |
GO:0072136 |
kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) |
| 0.2 |
0.6 |
GO:0060896 |
neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
| 0.2 |
0.6 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.2 |
0.6 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
| 0.2 |
2.3 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
0.8 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.2 |
0.6 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.2 |
1.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
0.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
0.8 |
GO:0072033 |
renal vesicle formation(GO:0072033) |
| 0.2 |
0.2 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.2 |
0.9 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.2 |
1.5 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
0.9 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
0.8 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.2 |
1.5 |
GO:1901985 |
positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.2 |
6.8 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
1.5 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.2 |
0.6 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.2 |
0.6 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 |
0.5 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.2 |
2.0 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.2 |
0.9 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 0.2 |
0.5 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.2 |
0.7 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.2 |
0.5 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 |
0.7 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA 5'-end processing(GO:0000966) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
1.2 |
GO:0021877 |
forebrain neuron fate commitment(GO:0021877) |
| 0.2 |
0.2 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.2 |
3.4 |
GO:0033260 |
telomere maintenance via semi-conservative replication(GO:0032201) nuclear DNA replication(GO:0033260) |
| 0.2 |
0.6 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.2 |
1.1 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.2 |
0.5 |
GO:0001832 |
blastocyst growth(GO:0001832) inner cell mass cell proliferation(GO:0001833) |
| 0.2 |
0.3 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.2 |
0.8 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.2 |
0.9 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.2 |
0.5 |
GO:0031223 |
auditory behavior(GO:0031223) |
| 0.2 |
0.8 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.2 |
0.8 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.7 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
12.6 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.1 |
0.6 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.1 |
0.6 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
0.7 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 |
0.4 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 |
0.7 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 |
1.3 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
1.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.5 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.3 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
1.0 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 |
0.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
1.5 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 |
0.5 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
0.4 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
0.3 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.4 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.1 |
0.6 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.4 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
0.3 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
1.1 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
0.4 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.4 |
GO:0071104 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.1 |
0.4 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.1 |
2.4 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.2 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 |
0.1 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 |
0.3 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.1 |
1.1 |
GO:0021517 |
ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
0.4 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
1.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.9 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
| 0.1 |
1.2 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.1 |
0.7 |
GO:0000089 |
mitotic metaphase(GO:0000089) |
| 0.1 |
0.4 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.1 |
0.4 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.1 |
0.7 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
1.5 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.2 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
0.3 |
GO:0019059 |
establishment of viral latency(GO:0019043) obsolete initiation of viral infection(GO:0019059) establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
1.5 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.1 |
0.4 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
0.5 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.1 |
0.4 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.3 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 |
0.5 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 |
0.3 |
GO:0048935 |
peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
4.5 |
GO:0016571 |
histone methylation(GO:0016571) |
| 0.1 |
0.3 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.4 |
GO:0071436 |
sodium ion export(GO:0071436) |
| 0.1 |
0.4 |
GO:0018352 |
glutamate decarboxylation to succinate(GO:0006540) protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 |
0.5 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.8 |
GO:0090049 |
regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
| 0.1 |
0.3 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.2 |
GO:0045768 |
obsolete positive regulation of anti-apoptosis(GO:0045768) |
| 0.1 |
0.5 |
GO:0051383 |
kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.1 |
0.3 |
GO:1901142 |
insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 0.1 |
0.9 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.1 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.1 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.8 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 |
0.3 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) |
| 0.1 |
0.5 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.3 |
GO:1904742 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.3 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 |
0.2 |
GO:0002874 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.1 |
0.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.8 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
1.3 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.1 |
0.6 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.2 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.1 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.1 |
0.7 |
GO:0060123 |
regulation of growth hormone secretion(GO:0060123) |
| 0.1 |
0.2 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
1.1 |
GO:0044786 |
cell cycle DNA replication(GO:0044786) |
| 0.1 |
0.4 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.1 |
0.3 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.2 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
0.1 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
| 0.1 |
0.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.6 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.6 |
GO:0051726 |
regulation of cell cycle(GO:0051726) |
| 0.1 |
1.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.5 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.1 |
0.3 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.1 |
0.2 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.4 |
GO:0009820 |
alkaloid metabolic process(GO:0009820) |
| 0.1 |
0.2 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.1 |
0.4 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.1 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.4 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.1 |
1.1 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
1.6 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.2 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.1 |
0.2 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.3 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.2 |
GO:0061298 |
progesterone secretion(GO:0042701) retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
1.2 |
GO:0006386 |
transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.1 |
0.3 |
GO:0010957 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.1 |
0.3 |
GO:0032933 |
SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.2 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.7 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.1 |
GO:0001845 |
phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
| 0.1 |
0.2 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.2 |
GO:0042560 |
10-formyltetrahydrofolate metabolic process(GO:0009256) 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
0.2 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.1 |
0.4 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
0.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.4 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.3 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.2 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.1 |
0.2 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.5 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.2 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.1 |
0.2 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
1.5 |
GO:0051320 |
mitotic S phase(GO:0000084) S phase(GO:0051320) |
| 0.1 |
0.3 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.7 |
GO:0016310 |
phosphorylation(GO:0016310) |
| 0.0 |
0.3 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.4 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
1.5 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 |
0.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 |
0.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.0 |
0.3 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 |
0.1 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.0 |
0.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 |
0.5 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.6 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.2 |
GO:0071044 |
histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.2 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 |
0.3 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.0 |
0.2 |
GO:0016265 |
obsolete death(GO:0016265) |
| 0.0 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
3.7 |
GO:0000216 |
obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
| 0.0 |
0.2 |
GO:0051294 |
establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
| 0.0 |
0.1 |
GO:0045953 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.0 |
0.0 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.0 |
0.0 |
GO:0021684 |
cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.0 |
0.2 |
GO:0030301 |
sterol transport(GO:0015918) cholesterol transport(GO:0030301) |
| 0.0 |
0.5 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.2 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.9 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.1 |
GO:0031558 |
obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
| 0.0 |
0.2 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.2 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.0 |
0.9 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
1.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.2 |
GO:0006310 |
DNA recombination(GO:0006310) |
| 0.0 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
1.2 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.5 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
0.8 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 |
0.3 |
GO:0048892 |
sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
| 0.0 |
1.6 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.0 |
0.4 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.3 |
GO:0060122 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
2.5 |
GO:0009791 |
post-embryonic development(GO:0009791) |
| 0.0 |
0.3 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.5 |
GO:1901663 |
quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
2.5 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 |
0.5 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.0 |
0.3 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.0 |
0.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.0 |
1.1 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
1.4 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.0 |
0.2 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.0 |
0.4 |
GO:1903078 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 |
0.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.1 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
1.2 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.0 |
0.4 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) actin filament reorganization(GO:0090527) |
| 0.0 |
0.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.6 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.4 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 |
0.9 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 |
0.3 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.4 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.1 |
GO:0051645 |
Golgi localization(GO:0051645) |
| 0.0 |
5.5 |
GO:0006470 |
protein dephosphorylation(GO:0006470) |
| 0.0 |
0.2 |
GO:0048755 |
branching morphogenesis of a nerve(GO:0048755) |
| 0.0 |
0.9 |
GO:0030641 |
regulation of cellular pH(GO:0030641) |
| 0.0 |
0.7 |
GO:1902583 |
multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
| 0.0 |
0.4 |
GO:0006885 |
regulation of pH(GO:0006885) |
| 0.0 |
0.6 |
GO:0048255 |
RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
| 0.0 |
0.1 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.0 |
0.5 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
| 0.0 |
0.2 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.2 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0090178 |
cochlea development(GO:0090102) cochlea morphogenesis(GO:0090103) establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.0 |
0.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.3 |
GO:0051322 |
anaphase(GO:0051322) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0060317 |
cardiac epithelial to mesenchymal transition(GO:0060317) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 0.0 |
0.6 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.0 |
0.2 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.0 |
0.1 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.0 |
0.9 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
1.4 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 |
0.1 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.2 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 |
0.6 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.3 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.2 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.2 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.2 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 |
0.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.2 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
1.2 |
GO:0001889 |
liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
| 0.0 |
0.5 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.0 |
4.3 |
GO:0006325 |
chromatin organization(GO:0006325) |
| 0.0 |
0.2 |
GO:0044349 |
nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
| 0.0 |
0.2 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.0 |
0.8 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.1 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.2 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) kynurenine metabolic process(GO:0070189) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.0 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.0 |
0.2 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.0 |
0.2 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.0 |
0.4 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.1 |
GO:0051445 |
regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
| 0.0 |
0.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.1 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.2 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.0 |
0.2 |
GO:0040023 |
establishment of nucleus localization(GO:0040023) |
| 0.0 |
1.8 |
GO:0009636 |
response to toxic substance(GO:0009636) |
| 0.0 |
0.7 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.1 |
GO:0071679 |
facial nucleus development(GO:0021754) cell proliferation in midbrain(GO:0033278) commissural neuron axon guidance(GO:0071679) |
| 0.0 |
0.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
1.8 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.3 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.3 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.0 |
0.4 |
GO:0009411 |
response to UV(GO:0009411) |
| 0.0 |
0.1 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.1 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.3 |
GO:0042982 |
amyloid precursor protein metabolic process(GO:0042982) |
| 0.0 |
0.1 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory gaseous exchange(GO:0043576) regulation of respiratory system process(GO:0044065) |
| 0.0 |
0.3 |
GO:0007126 |
meiotic nuclear division(GO:0007126) |
| 0.0 |
0.2 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.1 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.2 |
GO:0031960 |
response to corticosteroid(GO:0031960) |
| 0.0 |
1.1 |
GO:0044839 |
G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
| 0.0 |
3.0 |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
| 0.0 |
0.0 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.3 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
0.1 |
GO:0045060 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.0 |
0.1 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of JNK cascade(GO:0046329) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.0 |
GO:0000239 |
pachytene(GO:0000239) |
| 0.0 |
0.2 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.4 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
0.2 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.0 |
0.2 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.2 |
GO:0045727 |
positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
| 0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.2 |
GO:0001502 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.0 |
0.2 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.1 |
GO:0016358 |
dendrite development(GO:0016358) |
| 0.0 |
0.9 |
GO:0008016 |
regulation of heart contraction(GO:0008016) |
| 0.0 |
0.4 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.5 |
GO:1903825 |
organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
| 0.0 |
0.1 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
